The role of the allograft in the induction of donor-specific T cell hyporesponsiveness

被引:43
作者
Baker, RJ [1 ]
Hernandez-Fuentes, MP [1 ]
Brookes, PA [1 ]
Chaudhry, AN [1 ]
Lechler, RI [1 ]
机构
[1] Imperial Coll Sch Med, Hammersmith Hosp, Dept Immunol,Dept Renal Med, Div Med, London W12 0NN, England
关键词
D O I
10.1097/00007890-200108150-00020
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. With adequate immunosuppression the majority of renal allografts are accepted, despite the exceptional vigour of the T cell alloimmune response. Previous work from this laboratory has demonstrated that this is accompanied by significant reductions in the precursor frequencies of anti-donor T cells. We have also shown that parenchymal cells are tolerogenic in vitro. We propose that the reduction in T cell frequencies may be due to the interaction between circulating T cells and potentially tolerogenic graft parenchymal cells. Primed/memory T cells (CD45RO(+)) are the only subset capable of reaching the allograft and therefore we would predict that T cell hyporesponsiveness would develop predominantly in the CD45RO(+) subset due to their trafficking properties. Methods. Frequencies of IL-2 secreting CD45RA(+) and CD45RO(+) CD4(+) T cells in response to donor and third party stimulator cells were estimated in a series of renal transplant recipients, both before and after transplantation. Results. There were highly significant reductions in the frequencies of donor-specific CD4(+)CD45RO(+) T cells, when adjusted to control for the generalised effects of immunosuppression. There were no significant alterations in the frequencies of donor-specific CD4(+)CD45RA(+) T cells. Conclusions. In renal transplant recipients, donor-specific CD4(+) T cell hyporesponsiveness occurs predominantly in CD4(+) CD45RO(+) T cells which is the subset capable of trafficking through the graft.
引用
收藏
页码:480 / 485
页数:6
相关论文
共 37 条
[1]   Blockade of T-cell costimulation prevents development of experimental chronic renal allograft rejection [J].
Azuma, H ;
Chandraker, A ;
Nadeau, K ;
Hancock, WW ;
Carpenter, CB ;
Tilney, NL ;
Sayegh, MH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (22) :12439-12444
[2]  
Benichou G, 1999, J IMMUNOL, V162, P352
[3]  
BERG FMM, 1996, J EXP MED, V183, P1603
[4]   REVERSAL OF INVITRO T-CELL CLONAL ANERGY BY IL-2 STIMULATION [J].
BEVERLY, B ;
KANG, SM ;
LENARDO, MJ ;
SCHWARTZ, RH .
INTERNATIONAL IMMUNOLOGY, 1992, 4 (06) :661-671
[5]   Lymphocyte migration into tissue: The paradigm derived from CD4 subsets [J].
Bradley, LM ;
Watson, SR .
CURRENT OPINION IN IMMUNOLOGY, 1996, 8 (03) :312-320
[6]   DONOR-RECIPIENT MICROCHIMERISM IS NOT REQUIRED FOR TOLERANCE INDUCTION FOLLOWING RECIPIENT PRETREATMENT WITH DONOR-SPECIFIC TRANSFUSION AND ANTI-CD4 ANTIBODY - EVIDENCE OF A CLEAR ROLE FOR SHORT-TERM ANTIGEN PERSISTENCE [J].
BUSHELL, A ;
PEARSON, TC ;
MORRIS, PJ ;
WOOD, KJ .
TRANSPLANTATION, 1995, 59 (10) :1367-1371
[7]   Lymphocyte homing and homeostasis [J].
Butcher, EC ;
Picker, LJ .
SCIENCE, 1996, 272 (5258) :60-66
[8]   Clinical outcome of renal transplantation - Factors influencing patient and graft survival [J].
Cecka, M .
SURGICAL CLINICS OF NORTH AMERICA, 1998, 78 (01) :133-+
[9]   Late blockade of T cell costimulation interrupts progression of experimental chronic allograft rejection [J].
Chandraker, A ;
Azuma, H ;
Nadeau, K ;
Carpenter, CB ;
Tilney, NL ;
Hancock, WW ;
Sayegh, MH .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (11) :2309-2318
[10]   Persistent allopeptide reactivity and epitope spreading in chronic rejection of organ allografts [J].
Ciubotariu, R ;
Liu, ZR ;
Colovai, AI ;
Ho, E ;
Itescu, S ;
Ravalli, S ;
Hardy, MA ;
Cortesini, R ;
Rose, EA ;
Suciu-Foca, N .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (02) :398-405